The evolving burden of non-alcoholic fatty liver disease in China: A comprehensive analysis from the Global Burden of Disease (GBD) study 1990–2021
Nutrition and Health · 17.09.2026
DOI: 10.1177/02601060261486933 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrition and Health, online erschienen am 17.09.2026. Verfasst von Guanjun Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Fifth Hospital of Wuhan, Wuhan, China. Die Arbeit nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province, Wuhan Municipal Health Commission Research Fund.
Abstract (Originalsprache)
Background
Non-alcoholic fatty liver disease (NAFLD) poses a growing global public health challenge, yet its long-term trajectory and future burden in China remain insufficiently characterized.
Aim
This study quantified the disease burden of NAFLD in China from 1990 to 2021 and projected trends to 2036 using data from the Global Burden of Disease 2021 study.
Methods
Analytical methods included joinpoint regression, age-period-cohort modeling, decomposition analysis, frontier comparison, and autoregressive integrated moving average forecasting. Summary From 1990 to 2021, NAFLD incident cases in China increased from 6.18 million to 9.56 million, while prevalent cases rose from 137.11 million to 291.25 million. Age-standardized incidence showed fluctuating, wave-like patterns with marked gender differences—male incidence surpassed female incidence around 2016—whereas age-standardized mortality and disability-adjusted life year (DALY) rates declined steadily. Decomposition analysis indicated that population growth (59.39%) and epidemiological transition (62.34%) were the primary drivers of rising incidence, while population aging was the dominant factor for increased prevalence (48.03%), mortality (174.28%), and DALYs (323.98%). Projections suggest rising incidence in females, stable incidence in males, and a modest decline in overall prevalence over the next 15 years. In conclusion, NAFLD burden in China has risen substantially over the past three decades and is expected to persist, with shifting gender patterns and population aging as key drivers. These findings highlight the urgent need for targeted preventive interventions, especially among aging populations and women.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, The Fifth Hospital of Wuhan, Wuhan, China.
- Department of Emergency, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Chunli Xu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Wuhan Municipal Health Commission Research Fund
Zitieren
APA
Jiang, G., Zhang, P., Xu, S., Liang, M., Li, H., Liu, J., & Xu, C. (2026). The evolving burden of non-alcoholic fatty liver disease in China: A comprehensive analysis from the Global Burden of Disease (GBD) study 1990–2021. Nutrition and Health. https://doi.org/10.1177/02601060261486933
Vancouver
Jiang G, Zhang P, Xu S, Liang M, Li H, Liu J, et al. The evolving burden of non-alcoholic fatty liver disease in China: A comprehensive analysis from the Global Burden of Disease (GBD) study 1990–2021. Nutrition and Health. 2026. doi:10.1177/02601060261486933
BibTeX
@article{Jiang2026,
author = {Jiang, Guanjun and Zhang, Pan and Xu, Sikai and Liang, Mengjun and Li, Hao and Liu, Jing and Xu, Chunli},
title = {The evolving burden of non-alcoholic fatty liver disease in China: A comprehensive analysis from the Global Burden of Disease (GBD) study 1990–2021},
journal = {Nutrition and Health},
year = {2026},
doi = {10.1177/02601060261486933}
}
EUVIMED